Liu Yi, Zhao Dongmei, Dong Rui, Yang Xiaomeng, Zhang Yanqing, Tammimies Kristiina, Uddin Mohammed, Scherer Stephen W, Gai Zhongtao
Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Ji'nan, China.
Pediatric Health Institute, Qilu Children's Hospital of Shandong University, Ji'nan, China.
Am J Med Genet A. 2015 Jun;167(6):1381-5. doi: 10.1002/ajmg.a.37050. Epub 2015 Apr 6.
Exonic deletions disrupting the autism susceptibility candidate 2 (AUTS2) gene have been demonstrated as causal variants leading to neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) and developmental delay (DD). Here, we report on 830 kb de novo deletion at chromosome 7q11.22 in a 4-year-old male patient with ASD and DD. This deletion disrupts the promoter region and exon 1 of AUTS2, potentially leading to complete haploinsuffiency of the gene. In addition, we discuss the clinical presentation of the de novo deletion in the light of the previous studies describing deletions of AUTS2 in NDDs.
外显子缺失破坏孤独症易感候选基因2(AUTS2)已被证明是导致神经发育障碍(NDDs)如孤独症谱系障碍(ASD)和发育迟缓(DD)的致病变异。在此,我们报告一名患有ASD和DD的4岁男性患者染色体7q11.22处830 kb的新发缺失。该缺失破坏了AUTS2的启动子区域和外显子1,可能导致该基因完全单倍剂量不足。此外,我们根据先前描述NDDs中AUTS2缺失的研究,讨论了该新发缺失的临床表现。